These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11312328)

  • 1. During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.
    Bendinelli M; Pistello M; Del Mauro D; Cammarota G; Maggi F; Leonildi A; Giannecchini S; Bergamini C; Matteucci D
    J Virol; 2001 May; 75(10):4584-93. PubMed ID: 11312328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro.
    Giannecchini S; Matteucci D; Ferrari A; Pistello M; Bendinelli M
    J Virol; 2001 Sep; 75(18):8868-73. PubMed ID: 11507234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies.
    Siebelink KH; Bosch ML; Rimmelzwaan GF; Meloen RH; Osterhaus AD
    Vet Immunol Immunopathol; 1995 May; 46(1-2):51-9. PubMed ID: 7542412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein.
    Cammarota G; Matteucci D; Pistello M; Nicoletti E; Giannecchini S; Bendinelli M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):173-175. PubMed ID: 8834468
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
    Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
    Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
    Huisman W; Schrauwen EJ; Rimmelzwaan GF; Osterhaus AD
    Virus Res; 2008 Oct; 137(1):24-32. PubMed ID: 18602181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope.
    Richardson J; Fossati I; Moraillon A; Castelot S; Sonigo P; Pancino G
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():759-71. PubMed ID: 8627265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors.
    Giannecchini S; Pistello M; Del Santo B; Rovero P; Sichi O; Bendinelli M
    New Microbiol; 2004 Apr; 27(2 Suppl 1):77-84. PubMed ID: 15646068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization.
    Giannecchini S; Matteucci D; Bendinelli M
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):199-204. PubMed ID: 9491909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.
    Pistello M; Matteucci D; Giannecchini S; Bonci F; Sichi O; Presciuttini S; Bendinelli M
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1109-16. PubMed ID: 14607875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
    Freer G; Giannecchini S; Tissot A; Bachmann MF; Rovero P; Serres PF; Bendinelli M
    Virology; 2004 May; 322(2):360-9. PubMed ID: 15110533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env.
    Samman A; Logan N; McMonagle EL; Ishida T; Mochizuki M; Willett BJ; Hosie MJ
    J Gen Virol; 2010 Jan; 91(Pt 1):242-9. PubMed ID: 19776242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
    Sullender WM; Edwards KG
    Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker.
    Beaumont T; Quakkelaar E; van Nuenen A; Pantophlet R; Schuitemaker H
    J Virol; 2004 Jun; 78(11):5651-7. PubMed ID: 15140962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement.
    Corapi WV; Darteil RJ; Audonnet JC; Chappuis GE
    J Virol; 1995 May; 69(5):2858-62. PubMed ID: 7707508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
    Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
    Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.
    Flynn JN; Cannon CA; Reid G; Rigby MA; Neil JC; Jarrett O
    Immunology; 1995 Jun; 85(2):171-5. PubMed ID: 7543872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.
    Balasuriya UB; Maclachlan NJ; De Vries AA; Rossitto PV; Rottier PJ
    Virology; 1995 Mar; 207(2):518-27. PubMed ID: 7533965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.